Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Hyperopic LASIK results impressive at 6-month follow-up
Pekin, IL-Results from 6 months of follow-up in the Allegretto Wave (WaveLight Laser Technologie, Erlangen, Germany, and Lumenis) hyperopic LASIK clinical trial demonstrate excellent efficacy, safety, accuracy, and predictability, said William I. Bond, MD.
Related Videos
Related Content
